Drugs / melanoma vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00928902 Comparator | Nov 1999 → Apr 2001 | melanoma | University of Virginia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | melanoma vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00928902 ↗ |
| Modality | Vaccine | “vaccine comprising synthetic melanoma peptides” NCT00928902 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT00928902 ↗ |